Philips lands FDA clearance for its Spectral Diagnostic Suite

Evan Godt | | Health Imaging | Artificial Intelligence

The FDA has granted 510(k) clearance to Philips’ Spectral Diagnostic Suite, a set of advanced visualization and analysis tools designed for the Philips IQon Spectral CT.

The suite offers enhanced spectral viewing and advanced clinical capabilities within traditional CT applications, allowing for use of spectral information without special modes or workstations, according to the company. Viewing and analysis of spectral datasets could be done in the reading room or from remote locations.

Included in the Philips Spectral Diagnostic Suite is spectral enhanced comprehensive cardiac analysis, advanced vessel analysis and tumor tracking.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.